Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis
Nicholas Rouillard(Stanford Medicine), Mindie H. Nguyen(Stanford Medicine), Ramsey Cheung(VA Palo Alto Health Care System), Scott D. Barnett(Stanford Medicine), Xinrong Zhang(Tianjin Medical University), Richie Manikat(Stanford University), Leslie Y. Kam(Stanford Medicine)
Cited by 18
Related Papers
Angiotensin‐converting enzyme inhibitors prevent liver‐related events in nonalcoholic fatty liver disease
|Hepatology|2021|91
Trends in Hepatocellular Carcinoma Mortality Rates in the US and Projections Through 2040
|JAMA Network Open|2024|68
Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States
|JAMA Network Open|2020|62
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56